COMMUNIQUÉ DE PRESSE publié le 18/07/2024 à 19:15, il y a 2 mois 2 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 2,675 'A' ordinary shares at an average price of 708.00 GBp each as part of its share buyback programme London Stock Exchange Share Buyback Fuller, Smith & Turner PLC Treasury Shares Numis Securities Limited
BRÈVE publiée le 17/07/2024 à 18:13, il y a 2 mois 3 jours Fuller, Smith & Turner PLC : Transaction sur actions propres Actions Propres Rachat D'actions Actions Ordinaires Bourse De Londres Fuller
BRÈVE publiée le 17/07/2024 à 18:13, il y a 2 mois 3 jours Fuller, Smith & Turner PLC: Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Treasury Shares Fuller’s
COMMUNIQUÉ DE PRESSE publié le 17/07/2024 à 18:08, il y a 2 mois 3 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 10,406 'A' ordinary shares as part of its share buyback program, with the highest price paid at 708.00 GBp London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Treasury Shares Numis Securities Limited
BRÈVE publiée le 16/07/2024 à 19:11, il y a 2 mois 4 jours Fuller, Smith & Turner PLC : Transaction sur actions propres Actions Propres Rachat D'actions Bourse De Londres Fuller, Smith Et Turner Divulgation Et Transparence
BRÈVE publiée le 16/07/2024 à 19:11, il y a 2 mois 4 jours Fuller, Smith & Turner PLC: Transaction in own shares London Stock Exchange Share Buyback Treasury Shares Disclosure And Transparency Fuller, Smith & Turner
COMMUNIQUÉ DE PRESSE publié le 16/07/2024 à 19:06, il y a 2 mois 4 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC purchased 5,006 'A' ordinary shares at an average price of 709.5477p per share on 16th July 2024, as part of its buyback program Voting Rights London Stock Exchange Share Buyback Fuller, Smith & Turner PLC Numis Securities Limited
BRÈVE publiée le 15/07/2024 à 18:08, il y a 2 mois 5 jours Fuller, Smith & Turner PLC: Share Buyback Update London Stock Exchange Ordinary Shares Share Buyback Fuller’s
BRÈVE publiée le 15/07/2024 à 18:08, il y a 2 mois 5 jours Fuller, Smith & Turner PLC : mise à jour sur le rachat d'actions Rachat D'actions Actions Ordinaires Bourse De Londres Fuller
COMMUNIQUÉ DE PRESSE publié le 15/07/2024 à 18:03, il y a 2 mois 5 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares under share buyback programme, holding repurchased shares in Treasury. Details of transactions provided London Stock Exchange Fuller, Smith & Turner PLC Share Buyback Programme Numis Securities Limited Own Shares
Publié le 20/09/2024 à 17:40, il y a 6 heures 1 minute Availability of the 2024 Half-Year Financial Report
Publié le 20/09/2024 à 17:40, il y a 6 heures 1 minute Mise à disposition du Rapport Financier Semestriel 2024
Publié le 20/09/2024 à 23:30, il y a 11 minutes Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Publié le 20/09/2024 à 22:30, il y a 1 heure 11 minutes Electric Metals Announces Changes to its Board of Directors
Publié le 20/09/2024 à 22:15, il y a 1 heure 26 minutes Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Publié le 20/09/2024 à 22:00, il y a 1 heure 41 minutes Gold IRA Scam Warning Issued by IRAEmpire for US Consumers
Publié le 20/09/2024 à 22:58, il y a 42 minutes Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Publié le 20/09/2024 à 21:00, il y a 2 heures 41 minutes Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Publié le 20/09/2024 à 20:14, il y a 3 heures 26 minutes EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Publié le 20/09/2024 à 19:50, il y a 3 heures 50 minutes BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Publié le 20/09/2024 à 19:47, il y a 3 heures 53 minutes EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma